Search research articles
Contact Us
Filters
Showing results (191-200 of 211) with videos related to
Page
of 22
Sort By:
Blood Advances
|
April 14, 2026
Risk factor analysis of 115 children and adolescents with primary mediastinal B-cell lymphoma treated with DA-EPOCH-R
Friederike Meyer-Wentrup, Sarah Flora Jonas, Fabian Knörr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 19, 2012
Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation
Thomas Lehrnbecher, Robert Phillips, Sarah Alexander, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2017
Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update
Thomas Lehrnbecher, Paula Robinson, Brian Fisher, et al.
Microbial Genomics
|
May 17, 2023
NCTC3000: a century of bacterial strain collecting leads to a rich genomic data resource
Jo Dicks, Mohammed-Abbas Fazal, Karen Oliver, et al.
The Lancet. Haematology
|
April 24, 2023
Effect of rituximab on immune status in children with mature B-cell non-Hodgkin lymphoma: a prespecified secondary analysis of the Inter-B-NHL Ritux 2010 trial
Sarah Alexander, Anne Aupérin, Simon Bomken, et al.
Leukemia
|
September 30, 2018
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
Deepa Bhojwani, Richard Sposto, Nirali N Shah, et al.
Leukemia
|
March 8, 2019
Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
Deepa Bhojwani, Richard Sposto, Nirali N Shah, et al.
Pediatric Blood & Cancer
|
September 9, 2022
Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology Group
Caitlin W Elgarten, Joel C Thompson, Anne Angiolillo, et al.
The New England Journal of Medicine
|
June 4, 2020
Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children
Véronique Minard-Colin, Anne Aupérin, Marta Pillon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 3, 2019
Guideline for Antibacterial Prophylaxis Administration in Pediatric Cancer and Hematopoietic Stem Cell Transplantation
Thomas Lehrnbecher, Brian T Fisher, Bob Phillips, et al.
Page
of 22
Search research articles
Search
Showing results (191-200 of 211) with videos related to
Sort By:
Page
of 22
Blood Advances
|
April 14, 2026
Risk factor analysis of 115 children and adolescents with primary mediastinal B-cell lymphoma treated with DA-EPOCH-R
Friederike Meyer-Wentrup, Sarah Flora Jonas, Fabian Knörr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 19, 2012
Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation
Thomas Lehrnbecher, Robert Phillips, Sarah Alexander, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2017
Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update
Thomas Lehrnbecher, Paula Robinson, Brian Fisher, et al.
Microbial Genomics
|
May 17, 2023
NCTC3000: a century of bacterial strain collecting leads to a rich genomic data resource
Jo Dicks, Mohammed-Abbas Fazal, Karen Oliver, et al.
The Lancet. Haematology
|
April 24, 2023
Effect of rituximab on immune status in children with mature B-cell non-Hodgkin lymphoma: a prespecified secondary analysis of the Inter-B-NHL Ritux 2010 trial
Sarah Alexander, Anne Aupérin, Simon Bomken, et al.
Leukemia
|
September 30, 2018
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
Deepa Bhojwani, Richard Sposto, Nirali N Shah, et al.
Leukemia
|
March 8, 2019
Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
Deepa Bhojwani, Richard Sposto, Nirali N Shah, et al.
Pediatric Blood & Cancer
|
September 9, 2022
Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology Group
Caitlin W Elgarten, Joel C Thompson, Anne Angiolillo, et al.
The New England Journal of Medicine
|
June 4, 2020
Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children
Véronique Minard-Colin, Anne Aupérin, Marta Pillon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 3, 2019
Guideline for Antibacterial Prophylaxis Administration in Pediatric Cancer and Hematopoietic Stem Cell Transplantation
Thomas Lehrnbecher, Brian T Fisher, Bob Phillips, et al.
Page
of 22